Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Year-over-year total asset growth rate
3Y CAGR
+90.6%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
6.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 111.76% |
| Q3 2025 | 17.32% |
| Q2 2025 | 17.48% |
| Q1 2025 | 7.32% |
| Q4 2024 | 17.61% |
| Q3 2024 | 8.58% |
| Q2 2024 | 1.49% |
| Q1 2024 | 7.93% |
| Q4 2023 | 1.65% |
| Q3 2023 | -1.51% |
| Q2 2023 | -5.28% |
| Q1 2023 | -7.94% |
| Q4 2022 | 16.15% |
| Q3 2022 | -9.68% |
| Q2 2022 | -14.14% |
| Q1 2022 | -10.91% |
| Q4 2021 | -10.29% |
| Q3 2021 | -7.48% |
| Q2 2021 | -6.66% |
| Q1 2021 | 95.68% |
| Q4 2020 | -10.30% |
| Q3 2020 | -10.85% |
| Q2 2020 | -3.72% |
| Q1 2020 | -2.85% |
| Q4 2019 | -5.44% |
| Q3 2019 | -0.06% |
| Q2 2019 | -9.62% |
| Q1 2019 | 24.21% |
| Q4 2018 | 12.94% |
| Q3 2018 | -12.78% |
| Q2 2018 | 42.92% |
| Q1 2018 | -17.04% |
| Q4 2017 | 67.17% |
| Q3 2017 | -16.65% |
| Q2 2017 | -15.64% |
| Q1 2017 | 29.68% |
| Q4 2016 | -11.85% |
| Q3 2016 | -10.75% |
| Q2 2016 | -8.27% |
| Q1 2016 | -17.81% |